A global leader in proton beam technology
Conventional X-ray radiation is used widely in the treatment of many cancers worldwide.
Our next generation of particle treatment, which uses protons, pinpoints tumours more precisely and with more energy thereby potentially offering many patients higher disease-free survival rates and significantly less damage to surrounding healthy tissues.
Beyond providing these clinically superior cancer treatments, Advanced Oncotherapy is also committed to developing a proton therapy system which is much smaller and significantly less expensive than machines currently on the market.
This means that proton therapy will no longer be reserved for a minority of patients, but will be available to many more patients.
Follow Advanced Oncotherapy on Twitter @AdvOnco_AVO
- Alan Green talks Advanced Oncotherapy #AVO, Bidstack #BIDS, Brave Bison #BBSN & Xpediator #XPD on Vox Markets podcast
- Advanced Oncotherapy #AVO – Final Results statement plus CEO and Chairmans report
- Radiation for Mesothelioma: Could Proton Therapy Be the Answer? – Advanced Oncotherapy #AVO
- Advanced Oncotherapy #AVO – Update on Financing
- Advanced Oncotherapy #AVO – Successful testing supports the superior clinical outcomes of LIGHT
- Beams of Life: Mega in conversation with Professor Stephen Myers OBE
- Advanced Oncotherapy #AVO receives first part of Yantai distribution agreement payment
- Maintaining positive attitude helps Jupiter’s Gavin Snowhite beat cancer – TCPalm
- Brand Comms CEO Alan Green talks Salt Lake Potash #SO4 Advanced Oncotherapy #AVO & Volex #VLX
- Advanced Oncotherapy #AVO – UK Assembly and Testing Site Agreement
- Dad of two claims pioneering treatment in Prague saved his life – Irish Mirror
- Advanced Oncotherapy #AVO – GPSL Research on Advanced Oncotherapy Plc
- Proton RT for Prostate Cancer Has Reduced Toxicity, Higher Cost vs Other RT Options – Modern Medicine Network
- Advanced Oncotherapy #AVO – Peter Gyllenhammar AB shareholding
- Brand CEO Alan Green talks Prairie Mining #PDZ, Powerhouse Energy #PHE & Advanced Oncotherapy #AVO on Vox Markets podcast
- Advanced Oncotherapy #AVO – Update on Distribution Agreement
- Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy
- Advanced Oncotherapy #AVO – Hardman & Co Research: Confidence greatly boosted
- Therapeutic particles – CERN Courier
- Advanced Oncotherapy #AVO – Holdings in Company
- Advanced Oncotherapy #AVO – Completion of the Subscription Agreement
- Advanced Oncotherapy #AVO – Result of GM
- Advanced Oncotherapy #AVO – Dr Enrico Vanni director dealing
- Stocktube – Brand Communications’ Alan Green highlights his small cap stocks to watch in 2018.
- Advanced Oncotherapy #AVO – Notice of General Meeting
- Advanced Oncotherapy #AVO – LIGHT accelerator and Harley Street construction on track and on target
- Brand CEO Alan Green talks #TYM, #PDZ, #AVO, #KDNC and crypto with Andrew Scott on Proactive Investors
- Nicolas Serandour, CEO of Advanced Oncotherapy #AVO talks to Andrew Scott at Proactive Investors
- Advanced Oncotherapy #AVO – Hardman Research: Distribution agreement and capital increase
- Nicolas Serandour, CEO of Advanced Oncotherapy #AVO discusses Yantai deal & £37m equity investment with BRR Media
- Brand CEO Alan Green discusses todays developments at Advanced Oncotherapy #AVO on Vox Markets podcast
- Advanced Oncotherapy #AVO – Exclusive distribution agreement for China and other geographies & new equity investments for a total consideration of £37m
- Round the Clock Trader today features Dr David Paul of VectorVest and Brand CEO Alan Green
- Brand CEO Alan Green presents Small Cap Spotlight, looking at Prairie Mining #PDZ, Midwich #MIDW and Advanced Oncotherapy #AVO
- Combatting cancer in challenging environments – CERN
- Advanced Oncotherapy (AVO) – Progress at Harley Street, time-lapse video
- Directors Talk Q&A – Advanced Oncotherapy (AVO) Mike Sinclair – Disrupting the Market
- Brand CEO Alan Green talks Advanced Oncotherapy (AVO), RedstoneConnect (REDS) & AB Dynamics (ABDP) on Vox Markets podcast
- Hardman & Co research – Advanced Oncotherapy (AVO), technology advances & stronger balance sheet
- Advanced Oncotherapy (AVO) – Interim results announcement
- Three ways to make proton therapy affordable – Nature Weekly Journal
- Advanced Oncotherapy (AVO) Chief Ops Officer Ed Lee Q&A with Directors Talk
- Proton Beam Therapy and CERN Hadron Technology Are Fighting Cancer With LIGHT
- Advanced Oncotherapy (AVO) CEO Nicolas Serandour discusses the latest technological update with BRR Media
- Advanced Oncotherapy (AVO) LIGHT machine trials confirm system on track to treat tumours by end Q3 2018
- BRR Media interview with Gabriel Urwitz, Exec Chairman of AB Segulah – Advanced Oncotherapy (AVO)
- Advanced Oncotherapy (AVO) – Director dealing
- Advanced Oncotherapy (AVO) – Technological milestones update – CCL units
- Brand CEO Alan Green talks AstraZeneca (AZN), i3 Energy (I3E), Cadence Minerals (KDNC) & Advanced Oncotherapy (AVO) on Vox Markets podcast
- AVO – More LIGHT at the end of the tunnel – Wall Street Wires
- Advanced Oncotherapy (AVO) – Result of AGM
- Advanced Oncotherapy (AVO) – Financing facility provided by significant shareholders
- Advanced Oncotherapy (AVO) – Video and update on progress at Harley Street
- Advanced Oncotherapy (AVO) – Final results
- Advanced Oncotherapy (AVO) – Conversion of Convertible Loan Notes
- DirectorsTalk – Q&A with Professor Steve Myers at Advanced Oncotherapy (AVO).
- Advanced Oncotherapy (AVO) – Appointment of Senior Vice-President of Medical Physics
- AVO – Give me some LIGHT – Wall Street Wires
- Advanced Oncotherapy (AVO) – Additional financing agreement and new appointment
- Advanced Oncotherapy (AVO) – Technological milestones update
- Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers, Start of Treatment, Specifications & Company Analysis – Global Forecast to 2022
- Advanced Oncotherapy (AVO)- Bracknor waives requirement to call a General Meeting
- Advanced Oncotherapy (AVO) – Holdings in company
- Advanced Oncotherapy (AVO) – Harley Street construction update
- Advanced Oncotherapy (AVO) – Conversion of convertible loan notes
- Advanced Oncotherapy (AVO) – Update on Bracknor financing
- Advanced Oncotherapy (AVO) – Conversion of loan notes
- Advanced Oncotherapy (AVO) – Holdings in company
- Brand CEO Alan Green discusses Defenx (DFX) & Advanced Oncotherapy (AVO) on Vox Markets podcast
- New CERN particle accelerator may help both doctors and art sleuths – Advanced Oncotherapy (AVO)
- Advanced Oncotherapy (AVO) – Conversion of loan notes
- Advanced Oncotherapy (AVO) – Conversion of Convertible Loan Notes
- Advanced Oncotherapy (AVO) – Non-exec Professor Steve Myers buys 400,000 shares at 26p.
- Directors Talk – Q&A with Michel Baelen, Head of Regulatory Affairs at Advanced Oncotherapy Plc
- Advanced Oncotherapy (AVO) – Non-Exec Professor Chris Nutting buys 202,500 shares at 24.67p
- Advanced Oncotherapy (AVO) – Non-Exec Dr Nick Plowman invests GBP250,000 at 30p per share
- North America Radiotherapy Market by Equipment Type (Linear Accelerators, Radiation Therapy Simulators and Treatment Planning Systems)
- Advanced Oncotherapy (AVO) – Holdings in company
- Advanced Oncotherapy (AVO) – Holdings in company
- Advanced Oncotherapy (AVO) – Update on Bracknor financing
- Advanced Oncotherapy (AVO) – Executive Chairman buys 200,000 shares
- Advanced Oncotherapy (AVO) – Conversion of Convertible Loan Notes
- Advanced Oncotherapy (AVO) – Additional financing agreement
- Advanced Oncotherapy (AVO) – Director Dealing
- Advanced Oncotherapy (AVO) – Conversion of loan notes
- Advanced Oncotherapy (AVO) – Director dealing
- Brand CEO Alan Green talks Cadence Minerals (KDNC), Feedback (FDBK) & Advanced Oncotherapy (AVO) on TipTV
- Advanced Oncotherapy (AVO) – Conversion of loan notes
- Advanced Oncotherapy (AVO) sponsors Jupiter Medical Center Foundation’s 41st Annual Black Tie Ball
- Advanced Oncotherapy (AVO) – Conversion of loan notes
- Advanced Oncotherapy (AVO) – Total Voting Rights
- Advanced Oncotherapy (AVO) – Additional director dealing
- Advanced Oncotherapy (AVO) – Director Dealing
- Advanced Oncotherapy (AVO) – Result of General Meeting
- Advanced Oncotherapy (AVO) – Additional financing agreement
- Asia Cancer Market Update – MedTech Intelligence
- Advanced Oncotherapy (AVO) – Major Shareholder increases stake
- Brand CEO Alan Green talks Advanced Oncotherapy (AVO), Burford Capital (BUR) and Independent Oil & Gas (IOG) on Vox Markets podcast
- Advanced Oncotherapy (AVO) – Updated major shareholder list to include Bracknor Investment Group
- Advanced Oncotherapy (AVO) – Hardman Research: Delivery of LIGHT
- Advanced Oncotherapy (AVO) – Posting of Circular, Notice of General Meeting and Update on Financing Options
- Advanced Oncotherapy (AVO) – Investor presentation and Update
- Advanced Oncotherapy (AVO) – Conversion of convertible loan notes
- Advanced Oncotherapy (AVO) – Update on financing and Harley Street building work update
- Advanced Oncotherapy (AVO) – Financing agreement
- Advanced Oncotherapy (AVO) – Investor Presentations
- Advanced Oncotherapy (AVO) strengthens its board – Daily Telegraph
- Brand CEO Alan Green talks Advanced Oncotherapy (AVO), Conviviality (CVR), Safestyle (SFE) & Asiamet (ARS) on VOX Markets podcast
- Advanced Oncotherapy (AVO) – Appoints Dr Nick Plowman as Non-Executive Director
- Advanced Oncotherapy (AVO) – Significant Shareholder
- Advanced Oncotherapy (AVO) – Sinophi update
- Beaufort Securities view on Advanced Oncotherapy (AVO)
- Brand CEO Alan Green talks Angus Energy (ANGS), Feedback (FDBK), Advanced Onco (AVO) & Swallowfield (SWL) on the VOX Markets podcast
- Advanced Oncotherapy (AVO) – Appointment of Non-Executive Directors
- Advanced Oncotherapy (AVO) – Sinophi Update
- Advanced Oncotherapy (AVO) Non-dilutive financing plan update
- Doctors warn over cancer op cancellations amid NHS “pressure” – BBC
- Brand CEO Alan Green discussing May Brexit, Andalas Energy (ADL), Rio Tinto (RIO) & Advanced Oncotherapy (AVO) on TipTV
- Proton beam therapy used in tumour treatment in UAE – The National UAE
- Advanced Oncotherapy (AVO) – Additional Director Dealing
- Advanced Oncotherapy (AVO) – Additional Director Dealing
- Advanced Oncotherapy (AVO) – Significant Shareholder Dealing
- Brand CEO Alan Green discusses Wincanton (WIN), Advanced Oncotherapy (AVO) and Andalas Energy (ADL).
- Advanced Oncotherapy (AVO) – Additional director dealing
- Advanced Oncotherapy (AVO) – Further progress in the technical development of the LIGHT system
- Advanced Oncotherapy (AVO) – Additional Director Dealing
- Advanced Oncotherapy (AVO) – Additional Director Dealing
- Advanced Oncotherapy (AVO) – Director Dealing
- Advanced Oncotherapy (AVO) – Video of LIGHT system and testing facilities
- Brand CEO Alan Green talks about Tertiary Minerals (TYM) and Advanced Oncotherapy (AVO) on the VOX Markets podcast
- Advanced Oncotherapy (AVO) – Director Dealing
- Advanced Oncotherapy (AVO) – Update on Harley Street and Sinophi
- Advanced Oncotherapy (AVO) – Appointment of Joint Broker
- Advanced Oncotherapy (AVO) – Exercise of Options and Issue of Shares
- Advanced Oncotherapy (AVO) – Directorate Change
- Advanced Oncotherapy (AVO) – Result of Open Offer
- Advanced Oncotherapy (AVO) – Industrialisation agreement with Thales
- Advanced Oncotherapy (AVO) – Directorate change
- Advanced Oncotherapy (AVO) – Director Dealing
- Advanced Oncotherapy (AVO) – Harley Street planning permission granted
- Advanced Oncotherapy (AVO) – Open Offer
- Advanced Oncotherapy (AVO) – Directorate Change
- Advanced Oncotherapy (AVO) – Subscription & Proposed Open Offer
- Advanced Oncotherapy (AVO) – Half-Year Report
- Advanced Oncotherapy (AVO) – Appointment of International Director of Medical Physics
- Advanced Oncotherapy (AVO) – Holdings in Company
- Advanced Oncotherapy (AVO) – Holdings in Company
- Advanced Oncotherapy (AVO) – Exercise of Warrants, Issue of Shares and Holdings in Company
- Advanced Oncotherapy (AVO) – Holdings in Company
- Advanced Oncotherapy (AVO) – Director Dealing
LIGHT System and Testing Facilities
In this video on the Advanced Oncotherapy website, the company provides an inside look at the ground breaking technical development of the LIGHT system at its testing facility in Geneva as well as the critical involvement of CERN’s expertise in applying their knowhow to the treatment of cancers by Proton Beam Therapy.
For more information, visit the company website here